乳腺癌患者每日锥形束CT的自动剂量评估
本研究开发了一套全自动工作流程,用于在每日锥形束CT(CBCT)上评估乳腺癌患者实际接受的剂量,以分析解剖变化对剂量的影响并指导离线计划调整决策。在7个月内分析了647例患者的7454个分次,97%的患者中位乳腺临床靶区V95%≥95%。该流程在部分病例中提供了额外的决策信息,并识别出临床流程未发现的覆盖不佳病例。
要点
- 全自动流程可在每日CBCT上评估乳腺癌放疗的实际剂量。
- 647例患者7454个分次中,97%的患者中位乳腺临床靶区V95%≥95%。
- 该流程可识别临床未发现的覆盖不佳病例,可能需更密切的临床评估。
核心结论
- 研究开发了一套用于局部和局部区域乳腺放疗每日CBCT剂量评估的全自动工作流程。
- 该流程在解剖变化的患者中展现出辅助计划调整决策的潜力,并能识别可能接受次优治疗、需更密切临床评估治疗质量的患者。
研究设计与样本
- 研究开发了自动处理所有接受局部和局部区域放疗的乳腺癌患者每日CBCT的工作流程,将计划CT配准至CBCT以创建合成CT并传播轮廓,进行正向剂量计算并提取DVH参数生成报告。
- 在群体层面评估了7个月内647例患者的7454个分次,并在30例患者中进行个体化评估,其中10例与基于额外计划CT的临床评估进行比较。
主要发现
- 7个月内分析了647例患者的7454个分次。
- 97%的患者中位乳腺临床靶区V95%≥95%。
- 在具有额外计划CT的病例中,约半数存在与临床决策的可争议分歧,该流程本可为计划调整需求的决策提供有用的额外信息。
- 该流程还识别出临床流程中未发现的覆盖不佳病例。
临床怎么用
- 作者认为该流程可辅助解剖变化患者的计划调整决策,并突出可能接受次优治疗、需更密切临床评估治疗质量的患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: Our goal was to develop a workflow to automatically evaluate delivered dose on daily cone beam computed tomography (CBCT) in all breast cancer patients to assess dosimetric impact of anatomical changes and guide decision-making for offline plan adaptation. MATERIALS AND METHODS: The workflow automatically processes the daily CBCTs of all breast cancer patients receiving local and locoregional radiotherapy. The planning-CT is registered to the CBCT to create a synthetic CT and propagate contours. A forward dose calculation is performed, and DVH parameters are extracted and printed in a report. We evaluated the workflow on a group level and in a subset of 30 patients on a patient-specific level, including comparison to clinical evaluation on additional planning-CT in 10 patients. RESULTS: 7454 fractions in 647 patients were analyzed over a period of seven months. Median breast clinical target volume V95% was ≥ 95 % for 97 % of the patients. The workflow would have provided useful additional insights for decision-making for the requirement of plan adaptation, based on debatable disagreement with the clinical decision in half of the cases with an additional planning-CT. The workflow also identified cases with suboptimal coverage not identified in the clinical procedure. CONCLUSION: We developed a fully automated workflow for dose evaluation on daily CBCT for local and locoregional breast radiotherapy. We have demonstrated its potential for aiding decision-making for plan adaptation in patients with changing anatomy and its capability to highlight patients that may receive suboptimal treatment and require closer clinical evaluation of treatment quality.
引用
- Groot Koerkamp M, Stijnman P, Houweling A, et al. Automated dose evaluation on daily cone-beam computed tomography for breast cancer patients. Radiother Oncol. 2024. PMID: 39288822. doi:10.1016/j.radonc.2024.110541
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。